Gecko Biomedical’s first product may be a surgical sealant, but it has eyes on much more. The sealant's polymer has many potential applications.
Illumina Ventures reeled in $130 million in new funding, bringing its genomics-ventured fund to $230 million.
The complex and intertwined dual epidemics of poorly treated pain and opioid addiction require a combined, artful approach to secure the best possible results…
Avita Medical aims to raise $13.2 million to support its regenerative burn treatment through FDA submission and U.S. launch.
The lawsuit alleges that Patrick Miles schemed for more than a year to badmouth NuVasive and build a stake in Alphatec.
Shockwave's new financing will expand commercialization of its ultrasound balloon treatment for calcified artery disease and boost R&D.
Allegro Investment Fund led a $10 million series C that will boost commercialization and development of Sight Sciences' dry eye and surgical devices.
The series B equips Recursion to move beyond its initial focus on repurposing by applying its technology to the discovery of novel targets and drugs.
Analytics 4 Life bagged $25 million to support a clinical trial of its device that noninvasively screens for coronary artery disease.
BioSensics picked up more than $2.5 million in an NIH grant to develop a remote monitoring device for Huntington disease.
Days after the FDA approved Optinose’s nasal polyp drug, its commercialization will be the focus of a post-IPO spending spree.